Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPtimisation of Surgical Repair for Treating Insufficiency of the MItral Valve - Safety and Effectiveness Evaluation (OPTIMISE II)

NCT03908983 is registered in ClinicalTrials.gov with Kephalios as lead sponsor.

NCT NCT03908983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03908983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPtimisation of Surgical Repair for Treating Insufficiency of the MItral Valve - Safety and Effectiveness Evaluation (OPTIMISE II)
Lead sponsor
Kephalios
Phase
Not applicable
Overall status
Unknown status
Start date
November 20, 2019
Completion date
May 31, 2025
Enrollment
100 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve regurgitation